Skip to main content
Podcast banner

Media Resources

Featured Stories

Innovation
Sep 2, 2022
Couple finds personalized pain relief in identical devices

Jay and Sandra Aldrich experienced chronic pain for different reasons, but found relief in the same therapy.

Jun 27, 2022
Putting life in the foreground – and diabetes in the background

New Medtronic Medical Director, Jennifer McVean, M.D., brings fresh perspective

Jun 20, 2022
Health technology at the center of ‘Life Itself’

Geoff Martha showcases how AI, personalized care, and innovative therapies can bring better care to more patients.

Company News
Sep 21, 2022
Employees report they’re safe and Puerto Rico production is fully operating

Lessons learned after Maria are helping in the wake of Hurricane Fiona

Sep 16, 2022
Medtronic employee finds new take on volunteering

‘Everything starts with education’

Jul 25, 2022
Making fertility treatments accessible for employees

Kindbody benefit helps Medtronic employees find fulfillment

Our Impact
Sep 28, 2022
HACR partnership helps Medtronic develop Hispanic talent

Work toward zero barriers is recognized by the Hispanic Association on Corporate Responsibility

Sep 20, 2022
Medtronic Foundation launches its first Latino STEM students scholarship program

Students will receive up to $25,000 for education and other expenses

Sep 14, 2022
Lessons learned at Medtronic help one employee improve healthcare in Vietnam

Joe Lontai blends medical device skills with military service

Press releases
Sep 21, 2022
Medtronic announces closing of public offering of €3.5 billion of senior notes

Medtronic plc (the "Company") (NYSE: MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ( "Medtronic Luxco") has closed a registered public offering (the...

Sep 20, 2022
Medtronic receives FDA clearance for expanded indication of LINQ II™ insertable cardiac monitor for use in pediatric patients ages 2 and older

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global...

Sep 18, 2022
TCT 2022: SYMPLICITY HTN-3 trial data show sustained long-term blood pressure reductions with Medtronic renal denervation procedure

Long-term analysis from landmark renal denervation trial presented as Late Breaking Clinical Science, published simultaneously in The Lancet Data add to growing body of evidence supporting the...

See more

Get Notified
You may automatically receive updates from Medtronic by email.
* Required Fields
life transforming healthcare
our impact
esg report
protecting our planet
inclusion diversity
careers